rct
    2017
    High Quality

    Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction: a prospective, randomized, double-blind, placebo-controlled clinical trial

    Kamenov Z, Fileva S, Kalinov K, Jannini EA

    Published in Maturitas

    Methodology

    Prospective, randomized, double-blind, placebo-controlled trial of Tribulus terrestris extract (Tribestan) versus placebo in men with erectile dysfunction with or without hypoactive sexual desire disorder

    Key Findings

    Tribulus terrestris produced statistically significant improvement over placebo on IIEF scores in men with mild to moderate erectile dysfunction, with a safety profile similar to placebo.

    Conclusions

    Tribulus terrestris may modestly improve erectile function in mild to moderate ED, but the effect requires replication.

    Limitations

    Single 12-week trial, industry-linked product, uncertain generalizability to severe ED.

    Supplements Studied

    Tribulus terrestris improved IIEF erectile function and desire scores versus placebo without changing testosterone

    Outcomes Measured

    Tribulus improved sexual desire scores versus placebo

    Tribulus terrestris improved IIEF total and erectile function scores versus placebo

    Related Health Concerns

    Study Details

    Year:2017
    Sample Size:180
    Duration:12 weeks
    Quality Score:7/10

    Disclosures

    Funding

    Sopharma

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.